Update on Chronic Hepatitis B (CHB) Treatment

Abstract

The availability of newer antiviral agents, as well as comprehensive treatment recommendations, has equipped clinicians with sufficient options to formulate hepatitis B virus (HBV) treatment regimens and individualize therapeutic strategies. This article reviews the most recent guideline recommendations on goals, treatment indications, and endpoints, and resistance to anti-HBV treatment. In advocating an individualized approach to HBV treatment, currently available agents are further introduced separately.